$COKE

Coca-Cola Consolidated (COKE) Releases Q2 2026 Earnings: Revenue Up 10.6%, EPS Rises 10.7%

Coca-Cola Consolidated (COKE) reported Q2 2026 revenue of $2.1 billion, up 10.6% year over year. Gross profit rose to $778.4 million, while operating profit was about flat at $271.3 million. Net income attributable to common shareholders fell to $158.8 million, but diluted EPS increased 10.7% to $2.38. Operating cash flow was $215.4 million.

Original reporting
Published Aug 5, 2026, 9:03 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 11:46 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Coca-Cola Consolidated (COKE) Releases Q2 2026 Earnings: Revenue Up 10.6%, EPS Rises 10.7% — source image
Decision brief

The 30-second read

$COKENeutralMed
01

Why it matters

Traders can reassess near-term expectations for margins and earnings quality given cost of sales growth outpacing gross profit, despite revenue and EPS increases.

02

Market read

A fresh earnings print with mixed profitability signals can drive repricing of COKE’s margin outlook and forward earnings estimates.

03

What to watch

Operating profit is described as essentially flat while cost of sales accelerates, suggesting margin risk could dominate the next few quarters even if revenue stays resilient.

Relevance 8/10Novelty 8/10Timing: after-hours earnings release (published 2026-08-05 21:03 UTC)

Background

The article is a Q2 2026 earnings release summary for Coca-Cola Consolidated, including revenue, profit, EPS, and cash flow metrics.

Company-level read

Ticker impact

$COKENeutralMedium confidence
Context

Coca-Cola Consolidated reported Q2 2026 revenue of $2.1B (+10.6%) and diluted EPS of $2.38 (+10.7%), alongside flat operating profit.

Expected impact

Near-term reaction likely mixed, with upside from revenue/EPS growth offset by net income decline and margin pressure from higher cost of sales.

Evidence & confidence

The article provides directionally conflicting profitability signals: EPS up 10.7% while net income down 15.2%, plus cost of sales up 14.5% outpacing gross profit growth.

Market effects

Reinforces that bottler demand and pricing can support revenue growth, but cost inflation remains a key swing factor for margins.

No specific regional demand or macro driver is disclosed in the article.

Limited global read-through because the piece is company-specific and does not cite broader industry shocks.

Counterpoint

EPS growth may not translate into shareholder earnings power if net income continues to lag due to below-the-line items and rising input costs.

Key entities

  • Coca-Cola Consolidated, Inc.

    Reported Q2 2026 results: revenue $2.1B (+10.6%), diluted EPS $2.38 (+10.7%), net income $158.8M (-15.2%), operating profit essentially flat, operating cash flow $215.4M (+3.5%).

Related articles

$COKEMedAI 8/10

Coca-Cola Consolidated, Inc. (COKE): Results of Operations and Financial Condition

Coca-Cola Consolidated, Inc. (COKE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cokeq22026ex-991.htm EX-99.1 Document Exhibit 99.1 News Release Coca-Cola Consolidated Reports Second Quarter and First Half 2026 Results ■ Second quarter of 2026 net sales increased 11% versus the second quarter of 2025. ■ Gross profit in the second quarter of 2026 was

$COKEHighAI 9/10

Volume-led H1 supports upgraded 2026 guidance

Coca-Cola HBC AG reported six-month results to 3 July 2026, with organic revenue up 9.6% and reported net sales revenue up 10.8%. Comparable EBIT rose 15.2% to €760.1m and comparable EPS rose 15.2% to €1.51. The company upgraded 2026 guidance, now expecting organic revenue growth at the top end of 6% to 7% and organic EBIT growth of 8% to 10%.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.